CD-20 specific antibodies and methods of employing same
US9416187B2 · kind B2 · utility
5Cited by
31References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2004 |
| Grant date | Aug 16, 2016 |
| Priority date | — |
| Expiry date | May 11, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/732
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides monoclonal antibodies and antigen-binding fragments thereof that specifically bind to CD20, as well as pharmaceutical compositions comprising the same. The invention further provides methods of using the monoclonal antibodies, antigen-binding fragments, and pharmaceutical compositions, for example, in methods of depleting B cells or in treating B cell disorders. Also provided are cells, nucleic acids and methods for producing the monoclonal antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.